Latigo Biotherapeutics develops non-opioid pain treatments, focusing on selective Nav1.8 inhibitors.

Borealis Biosciences is a Vancouver-based company developing RNA therapeutics to address unmet needs in kidney disease.

Arsenal Biosciences, Inc. is a clinical-stage company developing programmable T cell therapies for solid tumor cancers using a computationally driven approach.

Star Therapeutics is a biotechnology company that develops first-in-class antibody therapies, primarily for hematology and immunology, and also generates additional biotech companies focused on discovering and advancing novel antibody therapies.